Robert O Cotes

22PUBLICATIONS
162CO-AUTHORS
Multimodal analysis and synthesisMedicinal and biomolecular chemistry not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsSocial program evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 22, 2026
The Rise of Medicare Advantage: Implications for Psychiatric Care.

|Oct 22, 2026
Outdated Product Labeling and Implications for Contemporary Standards of Care: The Example of Clozapine.

|Feb 25, 2026
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case Report.

Rafae Alam, Robert O Cotes, David R Goldsmith

|Jan 30, 2026
A Call to Action for Starting Clozapine: Increasing Clozapine Use and Safety in a Post-REMS Era.

Jonathan G Leung, Robert O Cotes

|Sep 30, 2025
A National Analysis of Facility-Level Clozapine Availability in U.S. Mental Health Services.

Samuel R Bunting, Aparna Das, Luca Iacobelli

|Apr 08, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.

Jose de Leon, Ross J Baldessarini, Richard Balon

Pageof 4

Frequent Collaborators

7 joint publications

Jonathan G Leung

5 joint publications

Ian R McGrane

5 joint publications

Jose de Leon

5 joint publications

Georgios Schoretsanitis